P

Inventor

PIEKEN WOLFGANG

US13 patents
⚠️ This page may combine multiple inventors who share the name “PIEKEN WOLFGANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NEXSTAR PHARMACEUTICALS INC

4 patents
US5958691ASep 28, 1999

High affinity nucleic acid ligands containing modified nucleotides

NEXSTAR PHARMACEUTICALS INC379 citations98
US5660985AAug 26, 1997

High affinity nucleic acid ligands containing modified nucleotides

NEXSTAR PHARMACEUTICALS INC534 citations98
US6184364B1Feb 6, 2001

High affinity nucleic acid ligands containing modified nucleotides

NEXSTAR PHARMACEUTICALS INC97 citations97
US5874532AFeb 23, 1999

Method for solution phase synthesis of oligonucleotides and peptides

NEXSTAR PHARMACEUTICALS INC55 citations96

MAX PLANCK GESELLSCHAFT

3 patents
US5672695ASep 30, 1997

Modified ribozymes

MAX PLANCK GESELLSCHAFT382 citations98
US5698687ADec 16, 1997

Modified ribozymls

MAX PLANCK GESELLSCHAFT95 citations95
US6890908B1May 10, 2005

Modified ribozymes

MAX PLANCK GESELLSCHAFT2 citations62

PROLIGO LLC

3 patents
US6737236B1May 18, 2004

Bioconjugation of macromolecules

PROLIGO LLC376 citations97
US6001966ADec 14, 1999

Method for solution phase synthesis of oligonucleotides and peptides

PROLIGO LLC34 citations92
US6262251B1Jul 17, 2001

Method for solution phase synthesis of oligonucleotides

PROLIGO LLC20 citations88

SIGMA ALDRICH CO

2 patents
US7427678B2Sep 23, 2008

Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method

SIGMA ALDRICH CO247 citations94
US7098326B2Aug 29, 2006

Methods for the integrated synthesis and purification of oligonucleotides

SIGMA ALDRICH CO1 citations51

MAX PLANCK GES EV

1 patent
US5817635AOct 6, 1998

Modified ribozymes

MAX PLANCK GES EV88 citations94